Sign in →

Test Code Epic LAB784 Aspergillus fumigatus, IgG Antibodies, Serum

Additional Codes

SQ code ASPRMM

Mayo code SASP

Reporting Name

Aspergillus fumigatus, IgG Ab, S

Specimen Type

Serum

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Useful For

Evaluation of patients suspected of having hypersensitivity pneumonitis (HP) induced by exposure to Aspergillus fumigatus

 

Evaluation of patients suspected of having HP who have documented environmental exposures to high-humidity environments


Specimen Required


Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.


Specimen Minimum Volume

0.3 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 21 days
  Frozen  21 days

Reference Values

<4 years: not established

≥4 years: ≤102 mg/L

Day(s) Performed

Monday through Friday

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

86606

LOINC Code Information

Test ID Test Order Name Order LOINC Value
SASP Aspergillus fumigatus, IgG Ab, S 26954-8

 

Result ID Test Result Name Result LOINC Value
SASP Aspergillus fumigatus, IgG Ab, S 26954-8

Reject Due To

Gross hemolysis OK
Gross lipemia OK
Gross icterus Reject

Method Name

Fluorescence Enzyme Immunoassay (FEIA)

Report Available

2 to 4 days

Secondary ID

9678

Method Description

The Phadia ImmunoCAP System specific IgG fluorescent enzyme immunoassay provides an in vitro method for measuring the concentrations of circulating specific IgG antibodies in human blood samples. Specific IgG from the patient's serum reacts with the antigen of interest, which is covalently coupled to an ImmunoCAP. After washing away nonspecific IgG, enzyme-labeled anti-IgG antibodies are added to form a complex. After incubation, unbound enzyme-anti IgG is washed away, and the bound complex is then incubated with a developing agent. After stopping the reaction, the fluorescence of the eluate is measured. The fluorescence is proportional to the amount of specific IgG, which is present in the patient's sample, ie, the higher the fluorescence value, the more specific IgG antibody is present.(Package insert: ImmunoCAP Aspergillus. Phadia AB; 10/2019)